Not Losing Any Weight on Mounjaro: What's Actually Going On

Are you actually at a dose that can produce results yet?

Mounjaro's starting dose is 2.5mg, and it exists for one reason: to let your body adjust before you move higher. At that level, meaningful weight loss is unlikely for most people, and that's by design. The real therapeutic work typically begins at 5mg and above, after the prescriber titrates upward through 4-week steps.

If you've been on 2.5mg for a month and the scale hasn't shifted, that's not a sign of failure; it's the normal picture. The timeline for Mounjaro to take effect in most people runs several weeks past the starter dose. Clinical trial data from SURMOUNT-1, published in the New England Journal of Medicine, showed the largest weight reductions accumulating gradually over 72 weeks (averaging around 20% at 15mg) which gives you a sense of the scale of the journey, not a sprint.

The honest question to ask yourself is: how long have you been at a therapeutic dose, meaning 5mg or higher? If the answer is under eight weeks, giving it more time is often the right call. If you've been at the same dose for months with no movement at all, that conversation belongs with your prescriber, a dose review may be appropriate.

What might be actively working against the medicine

Several things can blunt Mounjaro's effect even when you're taking it correctly. Poor sleep is one of the least discussed but most consistently evidenced. Short or disrupted sleep raises ghrelin (the hormone that drives hunger) and lowers the satiety signals that tirzepatide is trying to amplify, so the medicine is pushing in one direction while sleep deprivation pushes back.

Unmanaged or undiagnosed thyroid conditions, particularly hypothyroidism, can slow metabolic rate significantly. If you haven't had thyroid function checked recently, it's worth mentioning to your GP or prescriber. Certain medicines (including some antidepressants, corticosteroids, and antipsychotics) are also known to promote weight gain or resist loss, and your prescriber should know everything in your medicine cabinet.

Stress is another genuine factor. Chronically elevated cortisol promotes fat retention, particularly around the abdomen, and can override the appetite suppression that most people feel on tirzepatide. None of these are excuses; they're variables a clinician can help you identify. If you find yourself on Mounjaro but not losing weight, one of these underlying factors is often where the investigation should start. The patterns people describe when Mounjaro isn't shifting their weight often point back to one of these underlying factors.

The role food and activity choices play, honestly

Mounjaro does a remarkable job of reducing appetite. What it cannot do is make a deficit happen on its own if calorie intake has quietly stayed high. This is common: the medicine blunts hunger but doesn't eliminate food choices, and ultra-processed foods in particular are engineered to be eaten even without genuine appetite. Many people find they're eating less but still not less enough to move the scale, and if that sounds familiar, reading about why weight loss stalls on Mounjaro can help you pinpoint where the disconnect is happening.

Protein intake deserves a specific mention. When you eat less overall, getting enough protein becomes harder and more important, it preserves muscle mass, keeps you fuller for longer, and supports metabolic rate. The NHS patient guidance on tirzepatide recommends pairing treatment with dietary changes and increased activity, and that pairing is meant seriously, not as a legal footnote.

Activity doesn't need to mean the gym. But if the most movement in a day is a short walk, weight loss will be slower regardless of what the pen is doing. Some people set a reminder tied to something fixed in their day (say, a short walk after the school run) which builds the habit without needing willpower. For context on the cost side of private treatment as you decide whether to continue, the Eli Lilly UK price change background may be useful reading.

When to raise it with your prescriber directly

Plateaus, slow starts, and temporarily stalled scales are normal parts of treatment. What's less normal is truly zero change (no movement on weight, no change in how clothes fit, no reduction in appetite) after three or more months at a dose of 5mg or higher, and understanding what to do when you're on Mounjaro and not losing weight can help you decide whether that conversation with your prescriber is overdue. That picture warrants a clinical conversation, not just more patience.

Your prescriber can review whether the dose should be increased, whether a concurrent medical factor needs addressing, or whether Mounjaro is genuinely the right treatment for your situation. NICE's guidance on tirzepatide, TA1026, notes that if less than 5% weight loss has occurred after six months at the highest tolerated dose, continuing treatment should be reviewed. That's a useful benchmark to hold in mind, it protects you from staying on a medicine that isn't helping.

At nume, a real prescriber reads every consultation and every follow-up, not software, not a queue. If something about your progress doesn't add up, that's exactly the kind of detail our clinical team is there to work through with you. You can read more about how we work or look at our weight-loss treatment overview if you're weighing your options.